LibrarianMeg said:

Omega-3 index improvement on the lipid panel: often overlooked but my omega-3 index went from 3.7% to 8.7% over 8 months.

Tracking labs for the lipid panel — here's the panel I get every 3 months and why:

• CMP: glucose, electrolytes, kidney function, liver enzymes
• Lipid panel: total cholesterol, LDL, HDL, triglycerides
• A1C: 3-month glucose average
• hsCRP: inflammatory marker
• CBC: blood counts, anemia screening
• B12, folate, iron: nutritional deficiency screening
• TSH, free T4: thyroid monitoring
• Lipase: pancreatic safety check

Total cost with insurance: about $40 copay. Without insurance, request cash-pay pricing from Quest/Labcorp — usually $185.

LabKate said:

Fair, but phase 2 tolerability figures rarely survive contact with phase 3 scale.

Saving this. It is the first explanation that did not require me to already understand it. I will report back once I have actually tried it.

LibrarianMeg said:

Omega-3 index improvement on the lipid panel: often overlooked but my omega-3 index went from 3.7% to 8.7% over 8 months.

I would rather people stopped quoting the 24% as if it were a licensed outcome. It is a phase 2 result in a few hundred participants with no cardiovascular endpoint and no long-term safety data, and this board has a habit of treating pipeline numbers as settled.

jennifer_SEA said:

Trying to work out whether my panel improved or merely rearranged itself, because two of the numbers went the wrong way.

Advanced lipoprotein testing on the lipid panel — going beyond standard lipid panel:

The shift from small dense to large buoyant LDL is particularly important — it represents a fundamental change in the atherogenic profile.

Moderator note: the sourcing question belongs in the vendor section and has been split out. Thread quality here is what the rules are for. Keep it up.